Community Health Worker Support for Cancer Survivorship
Trial Summary
What is the purpose of this trial?
The objective of the proposed study is to scale social risk factor screening and referral for cancer survivors and to solidify information exchange between clinical and community settings in order to improve survivor health and well-being. This will be completed through three primary aims: 1) To ascertain workflow and map community resources needed to facilitate social risk factor screening and referral for breast and prostate cancer survivors in Washington, District of Columbia. 2) To determine impact of Community Health Worker (CHW) support on Black breast and prostate cancer survivor health and wellbeing as measured through quality of life (QOL) and social connection. 3) To determine impact of anti-racism training for staff and clinicians at three cancer centers on patient-reported discrimination.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Community Health Worker Support for Cancer Survivorship?
Research shows that community health worker (CHW) interventions can improve health-related quality of life and mental health, especially among low-income and minority patients with cancer. CHWs help patients access timely care and improve communication during hospital discharge, which can lead to better health outcomes.12345
Is Community Health Worker support safe for humans?
How does the Community Health Worker Support treatment for cancer survivorship differ from other treatments?
This treatment is unique because it involves community health workers (CHWs) who provide support and guidance to cancer survivors, helping them navigate complex health systems and access necessary services. Unlike traditional medical treatments, this approach focuses on improving psychosocial outcomes and addressing health inequities, particularly in marginalized communities.19101112
Research Team
Hannah Arem, PhD
Principal Investigator
Medstar Health Research Institute
Mandi Pratt-Chapman, PhD
Principal Investigator
George Washington University
Eligibility Criteria
This trial is for Black or African American individuals who have been diagnosed with stage I-III breast or prostate cancer and completed curative treatment, or those with stage IV of these cancers about 6 months post-diagnosis.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Community Health Worker Intervention
Participants receive support from a community health worker to assess social needs and provide support
Follow-up
Participants are monitored for health-related quality of life and social connectedness
Sustainability Assessment
Annual assessment of program sustainability using the Program Sustainability Assessment Tool
Treatment Details
Interventions
- Community Health Worker support
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medstar Health Research Institute
Lead Sponsor
George Washington University
Collaborator
Howard University
Collaborator
Georgetown University
Collaborator